See more : Immo-Beaulieu NV (BEAB.BR) Income Statement Analysis – Financial Results
Complete financial analysis of Emami Limited (EMAMILTD.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Emami Limited, a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Blue Safari Group Acquisition Corp. (BSGAR) Income Statement Analysis – Financial Results
- CoinSmart Financial Inc. (CONMF) Income Statement Analysis – Financial Results
- Ralco Agencies Ltd (RLCO.TA) Income Statement Analysis – Financial Results
- Universal Potash Corp. (UPCO) Income Statement Analysis – Financial Results
- Hota Industrial Mfg. Co., Ltd. (1536.TW) Income Statement Analysis – Financial Results
Emami Limited (EMAMILTD.NS)
About Emami Limited
Emami Limited manufactures and markets personal and healthcare products in India and internationally. It provides ayurvedic antiseptic cream, prickly heat powder, doodh kesar body lotion, vasocare herbal petroleum jelly, aloe vera gel, and hygiene products under the Boroplus brand; cool oil, extra thanda, gold ayurvedic oil, therapy ayurvedic body massage and stress relief oil, maxx cool talc, and cool talc under the Navratna brand; balm, balm ultra-power, quick relief roll-on, ortho vedic oil, healthcare products, pancharishta, nityam, kesari jivan, and ayurvedic hand sanitizers under the Zandu brand; radiance cream and instant radiance face wash for men under the Fair and Handsome brand; haircare products under the Kesh King brand; pain reliever balm under the Mentho Plus brand; and pain relief ointment under the Fast Relief brand. The company also offers prickly heat powder under the Dermicool brand; non sticky hair oil under the Emami 7 Oils in One brand; deodorants under the HE brand; hair colors under the Diamond Shine brand; talc under the Emami Golden Beauty brand; herbal fairness cream under the Emami Naturally Fair brand; home hygiene solutions under the Emasol brand; and normal, dry, and ultra-dry skin products under the Cream21 brand. Emami Limited was founded in 1974 and is headquartered in Kolkata, India.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 35.78B | 34.06B | 31.58B | 28.81B | 26.55B | 26.93B | 25.31B | 24.93B | 26.24B | 22.17B | 18.21B | 16.27B | 14.54B | 12.78B | 10.38B | 7.49B | 6.18B | 5.18B | 3.02B | 2.19B |
Cost of Revenue | 12.00B | 12.01B | 10.99B | 9.46B | 8.93B | 9.39B | 8.23B | 8.46B | 8.23B | 7.89B | 6.92B | 7.01B | 6.35B | 5.31B | 3.87B | 2.71B | 2.31B | 2.27B | 1.77B | 1.27B |
Gross Profit | 23.78B | 22.04B | 20.58B | 19.34B | 17.62B | 17.54B | 17.07B | 16.47B | 18.01B | 14.28B | 11.29B | 9.26B | 8.18B | 7.47B | 6.51B | 4.78B | 3.87B | 2.91B | 1.25B | 919.23M |
Gross Profit Ratio | 66.46% | 64.73% | 65.19% | 67.16% | 66.37% | 65.13% | 67.46% | 66.07% | 68.64% | 64.41% | 62.02% | 56.94% | 56.29% | 58.45% | 62.68% | 63.78% | 62.61% | 56.15% | 41.32% | 41.90% |
Research & Development | 247.10M | 219.51M | 0.00 | 0.00 | 0.00 | 205.27M | 223.64M | 207.42M | 186.85M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 4.20B | 0.00 | 332.98M | 396.85M | 408.88M | 301.45M | 243.68M | 235.68M | 342.56M | 302.62M | 176.37M | 163.21M | 470.38M | 872.01M | 654.57M | 836.29M | 677.41M | 180.50M | 112.98M | 103.62M |
Selling & Marketing | 6.52B | 5.61B | 6.04B | 5.30B | 5.31B | 5.33B | 5.32B | 5.03B | 5.92B | 4.49B | 3.25B | 2.95B | 3.61B | 3.07B | 2.64B | 1.90B | 1.62B | 1.60B | 350.14M | 248.15M |
SG&A | 10.72B | 5.61B | 6.37B | 5.70B | 5.72B | 5.63B | 5.56B | 5.27B | 6.26B | 4.80B | 3.43B | 3.11B | 4.08B | 3.95B | 3.30B | 2.73B | 2.29B | 1.78B | 463.12M | 351.77M |
Other Expenses | 0.00 | 689.30M | 82.97M | 81.75M | 75.23M | 75.05M | 81.65M | 69.84M | 75.22M | 146.39M | 27.06M | 98.88M | 29.16M | 0.00 | -121.28M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 10.72B | 15.89B | 14.41B | 14.11B | 14.03B | 13.52B | 12.98B | 11.96B | 13.71B | 9.21B | 7.27B | 5.93B | 6.25B | 4.86B | 4.12B | 3.50B | 2.93B | 2.27B | 774.75M | 602.45M |
Cost & Expenses | 22.84B | 27.90B | 25.40B | 23.57B | 22.96B | 22.90B | 21.21B | 20.42B | 21.93B | 17.10B | 14.18B | 12.94B | 12.60B | 10.17B | 7.99B | 6.22B | 5.24B | 4.54B | 2.55B | 1.88B |
Interest Income | 125.32M | 101.22M | 277.80M | 170.81M | 283.22M | 172.23M | 27.10M | 22.22M | 108.37M | 576.23M | 431.30M | 392.15M | 289.28M | 264.01M | 0.00 | 146.90M | 174.94M | 125.04M | 43.74M | 0.00 |
Interest Expense | 99.77M | 73.90M | 50.73M | 132.71M | 210.12M | 214.03M | 343.10M | 580.11M | 540.30M | 51.41M | 53.83M | 55.84M | 152.11M | 152.30M | 0.00 | 373.90M | 69.67M | 23.20M | 14.07M | 0.00 |
Depreciation & Amortization | 1.86B | 2.30B | 3.34B | 3.67B | 3.35B | 3.23B | 3.11B | 3.09B | 2.55B | 343.10M | 351.69M | 211.93M | 187.95M | 139.94M | 154.29M | 83.51M | 74.04M | 46.70M | 66.96M | 29.78M |
EBITDA | 9.90B | 9.14B | 10.41B | 9.53B | 7.36B | 7.50B | 7.39B | 7.90B | 7.31B | 6.32B | 4.98B | 3.97B | 3.33B | 3.00B | 2.55B | 1.36B | 1.01B | 690.77M | 539.42M | 346.56M |
EBITDA Ratio | 27.68% | 27.14% | 30.84% | 31.63% | 27.34% | 27.82% | 32.19% | 33.97% | 29.84% | 32.04% | 30.80% | 30.72% | 23.84% | 21.70% | 24.54% | 18.20% | 16.37% | 13.33% | 17.87% | 15.80% |
Operating Income | 12.94B | 6.39B | 6.23B | 5.24B | 3.65B | 4.08B | 5.04B | 5.38B | 5.28B | 6.76B | 5.26B | 4.79B | 3.28B | 2.63B | 2.39B | 1.28B | 937.96M | 644.07M | 472.46M | 316.79M |
Operating Income Ratio | 36.17% | 18.76% | 19.73% | 18.18% | 13.76% | 15.16% | 19.91% | 21.59% | 20.12% | 30.49% | 28.86% | 29.42% | 22.55% | 20.61% | 23.06% | 17.09% | 15.18% | 12.43% | 15.65% | 14.44% |
Total Other Income/Expenses | -5.03B | -5.49B | -5.48B | -5.84B | 148.19M | -5.78M | -164.85M | -276.21M | -1.05B | -2.79B | -1.32B | -1.10B | -288.37M | 58.12M | -337.47M | -232.63M | 85.94M | 103.63M | 29.67M | -3.83M |
Income Before Tax | 7.91B | 6.70B | 6.88B | 5.69B | 3.74B | 4.03B | 3.94B | 4.24B | 4.17B | 5.92B | 4.57B | 3.77B | 2.99B | 2.69B | 2.05B | 1.06B | 1.04B | 747.69M | 502.12M | 312.96M |
Income Before Tax Ratio | 22.10% | 19.66% | 21.79% | 19.75% | 14.07% | 14.98% | 15.56% | 16.99% | 15.90% | 26.72% | 25.11% | 23.15% | 20.57% | 21.06% | 19.74% | 14.13% | 16.81% | 14.43% | 16.64% | 14.27% |
Income Tax Expense | 666.97M | 421.40M | -1.49B | 1.14B | 712.70M | 1.01B | 862.61M | 836.17M | 584.91M | 1.07B | 547.03M | 529.59M | 401.21M | 404.10M | 352.11M | 141.25M | 126.56M | 85.73M | 9.50M | 20.90M |
Net Income | 7.24B | 6.40B | 8.39B | 4.55B | 3.03B | 3.03B | 3.07B | 3.40B | 3.59B | 4.86B | 4.02B | 3.24B | 2.59B | 2.29B | 1.70B | 917.45M | 912.63M | 661.97M | 492.62M | 292.06M |
Net Income Ratio | 20.22% | 18.78% | 26.57% | 15.79% | 11.41% | 11.26% | 12.14% | 13.65% | 13.68% | 21.90% | 22.10% | 19.90% | 17.81% | 17.90% | 16.35% | 12.25% | 14.77% | 12.77% | 16.32% | 13.31% |
EPS | 16.55 | 14.50 | 18.88 | 10.23 | 6.67 | 6.68 | 6.77 | 7.50 | 8.01 | 10.70 | 8.87 | 6.94 | 5.66 | 5.04 | 3.88 | 2.41 | 2.42 | 1.78 | 1.34 | 0.87 |
EPS Diluted | 16.55 | 14.50 | 18.88 | 10.23 | 6.67 | 6.68 | 6.77 | 7.50 | 8.01 | 10.70 | 8.87 | 6.94 | 5.66 | 5.04 | 3.88 | 2.41 | 2.42 | 1.78 | 1.34 | 0.87 |
Weighted Avg Shares Out | 437.27M | 441.08M | 444.26M | 444.48M | 453.18M | 453.94M | 453.94M | 453.94M | 453.94M | 453.94M | 453.94M | 453.94M | 453.94M | 453.94M | 437.83M | 381.35M | 372.87M | 372.87M | 366.90M | 337.80M |
Weighted Avg Shares Out (Dil) | 437.27M | 441.08M | 444.38M | 444.48M | 453.93M | 453.94M | 453.94M | 453.94M | 453.94M | 453.94M | 453.94M | 453.94M | 453.94M | 453.94M | 437.83M | 381.35M | 372.87M | 372.87M | 366.90M | 337.80M |
Source: https://incomestatements.info
Category: Stock Reports